Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Pharma Science

Strides Pharma Science

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 09, 16:00
328.25
3.85 (1.19%)
VOLUME 82,654
LIVE
NSE
Apr 09, 15:59
328.40
4.3 (1.33%)
VOLUME 828,898
News on Strides Pharma Science
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
StelisBiopharma, Pieris Forge alliance for Novel Anticalin therapeutics in ophthalmology

1.12 pm | 17 Dec 2013 |  Source: Moneycontrol.com

Stelis Biopharma, a subsidiary of Strides Arcolab, and Pieris AG announced the initiation of a long term collaboration for clinical development and co...

Sell Strides Arcolab: SP Tulsian 

4.44 pm | 10 Dec 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com is of the view that one may sell Strides Arcolab....

Special dividend of Rs 500/share to cost us $525mn: Strides 

2.01 pm | 10 Dec 2013 |  Source: CNBC-TV18

Strides Arcolab has a fairly strong organic growth strategy in place at the moment, says Group CEO & VC Arun Kumar....

Strides Arcolab: Outcome of board meeting

1.03 pm | 10 Dec 2013 |  Source: Moneycontrol.com

Strides Arcolab at its meeting held on December 10, 2013, has approved change of financial year of the Company from January-December to April-March ef...

Strides Arcolab fixes record date for special dividend

1.00 pm | 10 Dec 2013 |  Source: Moneycontrol.com

Strides Arcolab Ltd has informed that record date for determining the eligibility of shareholders for payment of special dividend will be December 20,...

Strides Arcolab approves special dividend of Rs 500

1.00 pm | 10 Dec 2013 |  Source: Moneycontrol.com

Strides Arcolab at its meeting held on December 10, 2013, has approved the a special dividend of Rs 500 per equity share of Rs 10 each to the sharehol...

Strides completes $1.75 bn sale of Agila to Mylan

3.11 pm | 05 Dec 2013 |  Source: PTI

The company, however, said it has agreed to a hold back of USD 250 million due to a warning letter received by it from the USFDA for one of its inject...

Hold Strides Arcolabs: Kunal Bothra 

12.24 pm | 05 Dec 2013 |  Source: CNBC-TV18

Kunal Bothra, head of Advisory at LKP is of the view that one may hold on to Strides Arcolabs....

Strides Arcolab to consider special dividend

8.19 am | 05 Dec 2013 |  Source: Moneycontrol.com

Strides Arcolab Ltd has informed that a meeting of the Board of Directors of the Company will be held on December 10, 2013, to consider, declaration o...

Strides Arcolab completes sale of Agila specialties division to Mylan

8.13 am | 05 Dec 2013 |  Source: Moneycontrol.com

Strides Arcolab has completed sale of its Agila Specialties Division to Mylan Inc. for a total consideration of up to USD 1.75 billion....

Buy Strides Arcolab; target of Rs 1225: Way2Wealth

12.30 pm | 20 Nov 2013 |  Source: Moneycontrol.com

Way2Wealth is bullish on Strides Arcolab and has recommended to buy the stock above Rs 958 levels with a stop loss of Rs 884 for the target price of R...

Strides Arcolab Sept qrtr profit falls; maintains outlook

4.29 pm | 14 Nov 2013 |  Source: Reuters

"In spite of a subdued quarter and delay in product approvals for the US market, the company is confident of meeting its guidance for the year," Arun ...

Strides Arcolab's Q3 results on Nov 14, 2013

3.28 pm | 06 Nov 2013 |  Source: Moneycontrol.com

Strides Arcolab Ltd has informed that a meeting of the Board of Directors of the Company will be held on November 14, 2013, to consider, the unaudited...

Strides Arcolab's subsidiary signs research collaboration agreement with Bio-Scaffold International Pte

1.46 pm | 23 Oct 2013 |  Source: Moneycontrol.com

Strides Arcolabs subsidiary Stelis Biopharma has entered into Research Collaboration Agreement with Bio-Scaffold International Pte Ltd to research an...

Decks clear for Mylan's $1.6 bn purchase of Agila

12.04 pm | 27 Sep 2013 |  Source: Reuters

Generic drugmaker Mylan Inc has won US antitrust approval to buy Agila, a unit of India's Strides Arcolab, subject to divesting some products....

US okays Mylan's purchase of Strides unit, with conditions

8.33 am | 27 Sep 2013 |  Source: Reuters

The companies will have to divest 11 generic injectable drugs as a condition of approving the deal, the FTC said. ...

Strides Arcolab gets USFDA approval for its Italian Semi-solids and Oinment facility

3.15 pm | 18 Sep 2013 |  Source: Moneycontrol.com

Strides Arcolab has received US FDA approval for Beltapharms facility at Milan, Italy. This state-of-the-art, EU and TGA (Australia) approved facilit...

Strides Arcolab: Updates on USFDA inspections

9.24 am | 16 Sep 2013 |  Source: Moneycontrol.com

Strides Arcolab Ltd has informed that the Sterile Manufacturing Facility 2 (SFF) at Bangalore of Agila Specialties Private Limited, a wholly owned sub...

Drugmakers draw more FDA scrutiny as US imports rise

10.17 am | 13 Sep 2013 |  Source: Reuters

India's drugmakers, battered by a rash of US regulatory rebukes including a record fine for Ranbaxy Laboratories Ltd , face closer FDA scrutiny as the...

Ailing pharma sector needs uniform drug standards: Ranbaxy 

1.32 pm | 05 Sep 2013 |  Source: CNBC-TV18

Given the fact that US gets 35 percent of its drugs from India, the regulator is only doing its job in looking closely at not just India's, but other ...

1 2 3 4
Quick Links for Strides Pharma Science
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.